Curated News
By: NewsRamp Editorial Staff
February 20, 2026

Johnson & Johnson Boosts BRAVE Coalition's Breast Cancer Reconstruction Mission

TLDR

  • Johnson & Johnson's donation to BRAVE Coalition Foundation provides a strategic advantage by enhancing brand loyalty and positioning the company as a leader in corporate social responsibility within healthcare.
  • Johnson & Johnson's contribution supports BRAVE Coalition's structured programs including patient education, surgeon collaboration, and community outreach to systematically improve breast reconstruction access and decision-making processes.
  • This donation empowers breast cancer survivors with knowledge and resources, creating a more equitable healthcare system where every woman can make informed choices about her recovery journey.
  • Since 2018, Johnson & Johnson has supported BRAVE Coalition's mission to educate women about breast reconstruction options regardless of insurance or socioeconomic status.

Impact - Why it Matters

This partnership matters because breast cancer affects approximately 1 in 8 women during their lifetime, and reconstruction decisions significantly impact survivors' physical and psychological recovery. Many women face barriers to reconstruction due to insurance limitations, lack of information, or socioeconomic factors. The BRAVE Coalition's work, amplified by Johnson & Johnson's support, addresses critical gaps in post-cancer care by providing education, advocacy, and access to reconstruction options. This collaboration helps ensure that survivors can make informed choices about their bodies and recovery, promoting better long-term outcomes and quality of life. By supporting patient-centered education and removing systemic barriers, this initiative contributes to more equitable healthcare for breast cancer survivors nationwide.

Summary

The BRAVE Coalition Foundation (Breast Restoration Advocacy & Education) has received a significant donation from Johnson & Johnson, strengthening their partnership that began in 2018. This contribution reinforces Johnson & Johnson's long-standing commitment to supporting breast cancer survivors and advancing patient-centered reconstruction education. The donation will help expand BRAVE Coalition's mission of advocacy, education, and equitable access, ensuring women have the resources needed to make informed decisions about their recovery journey.

According to Lisa Shumpert, President of BRAVE Coalition Foundation, this support allows the organization to expand its reach and deepen its impact, emphasizing the importance of standing beside patients throughout their entire reconstruction and healing process. The coalition works through various initiatives including patient education programs, surgeon collaboration, community outreach, and survivor resources to remove barriers to care and elevate awareness around breast reconstruction options. These efforts aim to ensure access regardless of insurance coverage or socio-economic status, empowering women with knowledge and advocacy throughout their breast reconstruction journey.

The BRAVE Coalition Foundation, founded in 2012 by Dr. Allen Gabriel and Dr. Christine Grogan, is the first 501(c)(3) not-for-profit charitable foundation dedicated to promoting education and awareness about resources for breast cancer survivors concerning breast reconstruction options. The organization believes every woman should have the right to decide how they shape their recovery from breast cancer. To learn more about or donate to the BRAVE Coalition Foundation, visit www.bravecoalition.org or follow them on social media platforms including Facebook, Instagram, Twitter, and LinkedIn.

Source Statement

This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Johnson & Johnson Boosts BRAVE Coalition's Breast Cancer Reconstruction Mission

blockchain registration record for this content.